We next adapted the so-call methylated bovine serum albumin (mBSA)/cytokine monoarticular arthritis model [3, 14–16] with exogenous IL-23 to determine whether we could develop an IL-23-driven arthritis model to explore putative downstream pathways. This evidence concerns the gene IL23A and arthritic joint disease.